Opportunity for a post-doctoral research position in a cancer epigenetics laboratory focused on the development of predictive and prognostic epigenetic biomarkers in lung cancers. The PI is also focused on Epithelial-to-Mesenchymal Transition (EMT) in lung cancer and the role epigenetic therapies play in countering therapeutic resistance related to EMT. The PI is part of a larger group of basic and translational cancer research laboratory led by the co-director of the cancer epigenetics center at M.D. Anderson Cancer Center. The PI has active ongoing collaborations with several clinical investigators and the lung cancer SPORE at M.D. Anderson. The successful applicant must have a sophisticated understanding of molecular biology techniques and a solid foundation in the underlying science with relevant laboratory experience. Prior experience in epigenetics, DNA methylation, or in biomarker research is a major advantage. Should be able to work independently and manage daily research projects, taking the leading role in the design of experiments, analysis of data, writing of manuscripts and grants, and presentation of work at institutional and national meetings.
Qualifications:
Advanced graduate degree (PhD or equivalent) in molecular biology, cancer biology, epigenetics, or a related field awarded or anticipated at the time of application.

If interested in this position, please contact:
Steven H. Lin, M.D., Ph.D.
Assistant Professor
Department of Radiation Oncology
The University of Texas M.D. Anderson Cancer Center
Unit 97
1515 Holcombe Blvd.
Houston TX 77030
shlin@mdanderson.org